2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$11.45+$0.06 (+0.53%)
Price as of Sep 11, 2026 7:40 PM EDT- $1.0BMarket Cap
- 39.07%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$11.45+$0.06 (+0.53%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.39 | ||
Change | -$0.18 (-1.56%) | ||
Open | $11.58 | ||
High | $11.75 | ||
Low | $11.34 | ||
Previous Close | $11.57 | ||
Volume | 2,117,528 | ||
30-Day Average Volume | 2,396,265 | ||
1-Week Change | -14.04% | ||
1-Month Change | 14.70% | ||
1-Year Change | 39.07% | ||
3-Year Change | 13.90% | ||
5-Year Change | -44.98% | ||
Fundamentals | |||
Shares Outstanding | 89.0M | ||
Total Assets | $587.8M | ||
Market Cap | $1.0B | ||
Enterprise Value | $952.8M | ||
Period: QTR TTM FY | |||
Revenue | $9.1M | ||
Net Income | -$68.3M | ||
Free Cash Flow | -$63.2M | ||
EBIT | -$68.3M | ||
EBITDA | -$68.0M | ||
Net Working Capital | $441.2M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 104 | ||
P/B | 21 | ||
P/E | -15 | ||
PEG | -2 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue